Hacker News Reader

It's unusual but not unheard of for trials to be stopped ahead of schedule because of this - the treatment is so clearly and substantially beneficial it's considered unethical to continue depriving the control group of the treatment.

When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches:

https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.111...

View on HN

In this case the alternative to the trial would be the ‘dangerous’ option of no treatment. So that doesn’t really apply here.

How does it not apply here? Are you saying that no treatment (right now there are no standards of care for COVID-19) is not dangerous? If I recall correctly, that option is leading to people dying.

Read again.

> In this case the alternative to the trial would be the […] option of no treatment

So the alternative is what we do now, which indeed is the ‘dangerous’ option.

Reply on news.ycombinator.com